AMENDED AND RESTATED ASSET PURCHASE AGREEMENT BY AND BETWEEN RESPONSE GENETICS, INC., A DELAWARE CORPORATION AND CANCER GENETICS, INC., A DELAWARE CORPORATION DATED AS OF AUGUST 14, 2015Asset Purchase Agreement by And • August 21st, 2015 • Cancer Genetics, Inc • Services-medical laboratories • Delaware
Real Property Leases Schedule 1.1(a) Contracts Schedule 1.1(b) Included Pharma Receivables Schedule 1.1(f) Included Avoidance Actions Schedule 1.1(o) Excluded Assets Schedule 1.2 Unpaid Sick Pay, Vacation and Other Paid Time Off Schedule 1.3(a)(ii) Conduct of Business Schedule 4.1(b) Access to Information (Employees - Supervised) Schedule 4.3(1) Access to Information (Employees - Unsupervised) Schedule 4.3(1) Transfer Employee Credit Schedule 4.6(b) Access to Personnel Schedule 4.8
August 17, 2015Asset Purchase Agreement • August 21st, 2015 • Cancer Genetics, Inc • Services-medical laboratories
Reference is made to that certain Amended and Restated Asset Purchase Agreement dated August 17, 2015 (the “APA”), between Response Genetics, Inc., a Delaware corporation and Chapter 11 Debtor and Debtor in Possession in the Bankruptcy Case pending in the Bankruptcy Court (“Seller”), and Cancer Genetics, Inc., a Delaware corporation (“Buyer”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to them in the APA.
